Monday, October 4, 2010

RegenMD - The Business of Stem Cell Research

     
    RegenMD    
   
The Business of Stem Cell Research
October 3, 2010 at 11:09 PM
 
He says business interest in what he calls 'regenerative medicine' has grown dramatically. "More and more we see private enterprise, venture capital ...
See all stories on this topic »
   
   
Austrian Approval For Preflucel
October 3, 2010 at 6:59 PM
 
This segment, accounting for 42.5% of revenues, also offers products for regenerative medicine such as biosurgery products and vaccines. ...
See all stories on this topic »
   
     
 
This email was sent to agupta1213+termsc@gmail.com.
Delivered by Feed My Inbox
230 Franklin Road Suite 814 Franklin, TN 37064
Account Login
Unsubscribe Here Feed My Inbox
 
     

No comments: